BANK VONTOBEL/CALL/MERCK & CO./150/0.1/20.12.24 Share Price

Warrant

DE000VD3VZN9

Real-time Boerse Frankfurt Warrants 05:23:24 05/06/2024 pm IST
0.168 EUR +6.33% Intraday chart for BANK VONTOBEL/CALL/MERCK & CO./150/0.1/20.12.24
Current month+30.58%
1 month-6.51%
Date Price Change
05/24/05 0.168 +6.33%
04/24/04 0.158 +3.95%
03/24/03 0.152 +25.62%
31/24/31 0.121 -16.55%
30/24/30 0.145 +18.85%

Real-time Boerse Frankfurt Warrants

Last update June 05, 2024 at 05:23 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD3VZN
ISINDE000VD3VZN9
Date issued 10/04/2024
Strike 150 $
Maturity 20/12/2024 (198 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.29
Lowest since issue 0.118
Spread 0.01
Spread %5.62%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.7 USD
Average target price
142.7 USD
Spread / Average Target
+10.86%
Consensus